HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Granulocyte-specific monoclonal antibody technetium-99m-BW 250/183 and indium-111 oxine-labelled leucocyte scintigraphy in inflammatory bowel disease.

Abstract
Thirty-three patients suspected of suffering from inflammatory bowel disease were studied. Autologous leucocytes were labelled with indium 111 oxine and re-injected simultaneously with 0.3-0.5 mg of technetium 99m granulocyte-specific monoclonal antibody BW 250/183. Two scans were obtained, the early scan 3-4 h postinjection (p.i.) and the late scan 18-24 h p.i. Using the endoscopy study as standard, the diagnostic accuracy of both agents was determined. Sensitivity, specificity and accuracy of 111In scans was 88.8%, 100.0% and 93.7% at 4 h and 94.7%, 100.0% and 96.9% at 24 h, respectively. Concerning the results using antibodies, the values were 61.1%, 100.0% and 78.1% at 4 h and 78.9%, 92.8% and 84.8% at 24 h, respectively. Segmental analysis showed concordance in 89.3% and 93.3% of the cases at 4 and 24 h, respectively. Though less sensitive and less accurate than scanning employing indium 111 leucocytes, BW 250/183 granulocyte-specific scintigraphy can be used for inflammatory bowel disease diagnosis and localization.
AuthorsI Segarra, M Roca, C Baliellas, L Vilar, Y Ricart, J Mora, R Puchal, J Martin-Comin
JournalEuropean journal of nuclear medicine (Eur J Nucl Med) Vol. 18 Issue 9 Pg. 715-9 ( 1991) ISSN: 0340-6997 [Print] Germany
PMID1657610 (Publication Type: Journal Article)
Chemical References
  • Indium Radioisotopes
  • Organometallic Compounds
  • indium oxine
  • Oxyquinoline
  • Sodium Pertechnetate Tc 99m
Topics
  • Adult
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Indium Radioisotopes
  • Inflammatory Bowel Diseases (diagnostic imaging, epidemiology)
  • Leukocytes
  • Male
  • Organometallic Compounds
  • Oxyquinoline (analogs & derivatives)
  • Predictive Value of Tests
  • Radioimmunodetection
  • Sensitivity and Specificity
  • Sodium Pertechnetate Tc 99m

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: